Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature

July 2014
Oncology Letters;2014, Vol. 8 Issue 1, p291
Academic Journal
For the majority of inoperable esophageal cancer cases, chemoradiotherapy is the most suitable treatment option. Cetuximab may provide certain benefits, however, this can be an expensive therapy. Additionally, stereotactic body radiation therapy (SBRT) is typically contraindicated for esophageal cancer due to the potential for esophageal perforation and stenosis. The use of combined chemotherapy plus endostar with sequential SBRT for the treatment of esophageal squamous cancer has not been reported. In the current study, the case of a 71-year-old female with esophageal squamous cancer diagnosed 2 years prior is presented. Surgery and four cycles of cisplatin plus 5-fluorouracil chemotherapy had been administered. The patient showed recurrence at the paratracheal lymph node, exhibited severe dyspnea (grade III) and required a semi-liquid diet. Four cycles of the docetaxel, 5-fluorouracil and nedaplatin regimen plus endostar (3 mg; days 1-14; intravenously) with sequential SBRT (3300 cGy in 10 fractions) was administered. Following treatment, the symptoms of the patient completely disappeared, and objective efficacy evaluation indicated complete remission. At the time of writing, the patient is living without discomfort and the progression-free survival is >8 months. In conclusion, the present case indicates that combined treatment of chemotherapy and endostar with sequential stereotactic radiotherapy is a safe and effective option for the management of esophageal cancer.


Related Articles

  • Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer. Kobayashi, R.; Yamashita, H.; Okuma, K.; Shiraishi, K.; Ohtomo, K.; Nakagawa, K. // Diseases of the Esophagus;Jan2014, Vol. 27 Issue 1, p72 

    The purpose of this retrospective study was to assess the efficacy of salvage radiation therapy ( RT) or chemoradiation therapy ( CRT) for locoregional recurrence ( LR) of esophageal cancer after curative surgery. Forty-two patients who received salvage RT or CRT for LR of esophageal cancer...

  • Treatment strategies in recurrent esophageal or junctional cancer. Butter, R.; Lagarde, S. M.; van Oijen, M. G. H.; Anderegg, M. C. J.; Gisbertz, S. S.; Meijer, S. L.; Hulshof, M. C. C. M.; Bergman, J. J. G. H. M.; van Berge Henegouwen, M. I.; van Laarhoven, H. W. M. // Diseases of the Esophagus;Sep2017, Vol. 30 Issue 9, p1 

    Little evidence is available about survival rates in patients with recurrent disease after potentially curative surgery for esophageal or junctional cancer. Only in limited occasions, potentially curative salvage strategies are available. The aim of this study is to analyze survival rates and...

  • Evaluating patterns of failure and salvage therapy for patients treated with primary stereotactic body radiation therapy for early stage non-small cell lung cancer. Mezera, Megan; Chandrasekhar, Mahesh; Kloecker, Goetz; van Berkel, Victor; Bousamra, Michael; Dunlap, Neal E. // Journal of Solid Tumors;May2014, Vol. 4 Issue 2, p4 

    Objective: The purpose of this study is to evaluate patterns of failure after stereotactic body radiation therapy for early stage NSCLC and determine the role of salvage therapy on patient outcome. Methods: Eighty-two consecutive medically inoperable patients treated with definitive SBRT for...

  • Salvage chemoradiotherapy for locally advanced esophageal carcinomas. Nakajima, Y.; Kawada, K.; Tokairin, Y.; Miyawaki, Y.; Okada, T.; Ryotokuji, T.; Fujiwara, N.; Saito, K.; Fujiwara, H.; Ogo, T.; Okuda, M.; Nagai, K.; Miyake, S.; Kawano, T. // Diseases of the Esophagus;Jul2015, Vol. 28 Issue 5, p460 

    SUMMARY 'Salvage chemoradiotherapy ( CRT)' was introduced in 2005 to treat thoracic esophageal carcinomas deemed unresectable based on the intraoperative findings. The therapeutic concept is as follows: the surgical plan is changed to an operation that aims to achieve curability by the...

  • Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases. Kickingereder, Philipp; Hamisch, Christina; Suchorska, Bogdana; Galldiks, Norbert; Visser-Vandewalle, Veerle; Goldbrunner, Roland; Kocher, Martin; Treuer, Harald; Voges, Juergen; Ruge, Maximilian // Journal of Neuro-Oncology;Dec2014, Vol. 120 Issue 3, p615 

    Treatment options for inoperable glioblastoma are limited. Low-dose-rate stereotactic iodine-125 brachytherapy (SBT) has been reported as an effective and low-risk treatment option for circumscribed low-grade gliomas and brain metastases. The present study evaluates this treatment approach for...

  • Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge. Navarria, Pierina; Ascolese, Anna Maria; Tomatis, Stefano; Reggiori, Giacomo; Clerici, Elena; Villa, Elisa; Maggi, Giulia; Bello, Lorenzo; Pessina, Federico; Cozzi, Luca; Scorsetti, Marta // Cancer Research & Treatment;2016, Vol. 48 Issue 1, p37 

    Purpose: The aim of this study was to evaluate outcomes of hypofractionated stereotactic radiation therapy (HSRT) in patients re-treated for recurrent high-grade glioma. Materials and Methods: From January 2006 to September 2013, 25 patients were treated. Six patients underwent radiation therapy...

  • Early experience with cyberknife stereotactic radiation therapy for chordoma. Beltramo, G.; Bergantin, A.; Martinotti, A. S.; Vite, C.; Ria, F.; Invernizzi, M.; Bianchi, L. C.; Romanelli, P. // Journal of Radiosurgery & SBRT;2013 Supplement 2.1, Vol. 2, p41 

    Purpose: Although considered slow-growing, low-grade malignancies, chordomas are locally aggressive and destructive tumors with high recurrence rates. We report preliminary results of stereotactic radiosurgery (CK/SRS) using the Cyberknife system for primary and recurrent chordomas. Material and...

  • Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer. Makazu, M.; Kato, K.; Takisawa, H.; Yoshinaga, S.; Oda, I.; Saito, Y.; Mayahara, H.; Ito, Y.; Itami, J.; Hamaguchi, T.; Yamada, Y.; Shimada, Y. // Diseases of the Esophagus;Jan2014, Vol. 27 Issue 1, p42 

    Local failure after definitive chemoradiotherapy ( CRT) for stage IB, II, and III esophageal cancer is one of the causes of poor outcome. Endoscopic mucosal resection ( EMR) is an effective treatment for superficial esophageal cancer. However, its feasibility as a salvage treatment for local...

  • Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting. Murphy, C. C.; Hofstetter, W. L.; Correa, A. M.; Ajani, J. A.; Komaki, R. U.; Swisher, S. G. // Diseases of the Esophagus;Sep2013, Vol. 26 Issue 7, p708 

    Trimodality therapy with neoadjuvant chemoradiation followed by surgery significantly improves the survival of locally advanced (clinical stage IIA-III) esophageal cancer patients compared to treatment with surgery alone. This has resulted in an increased use of neoadjuvant therapy in recent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics